Skip to Main Content

Paper Details

Estimated Annual Spending on Aducanumab in the US Medicare Program.
JAMA Health Forum
13
2022
Author NameAffiliation
John N MafiDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at university of california los angeles
John N MafiRAND Corporation
Chi-Hong TsengDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at university of california los angeles
Chi-Hong TsengDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at university of california los angeles
Catherine A SarkisianDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at university of california los angeles
Catherine A SarkisianVA Greater Los Angeles Healthcare System
Catherine A SarkisianDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at university of california los angeles
Catherine A SarkisianVA Greater Los Angeles Healthcare System
Bruce E LandonBeth Israel Deaconess Medical Center, Harvard Medical School
Bruce E LandonHarvard Medical School
  • 1 - 10

Datasets